Stock Report

All about this stock under one free report Last Updated: 02-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

AcelRx Pharmaceuticals (ACRX) Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.13

up-down-arrow $0.00 (0.24%)

As on 12-Mar-2024 09:30EDT

Market cap

info icon

$15 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 140.17 11.51 -63.24 -50.65 -21.26
EBIT -- -- -113.43 21.97 12.79
Net Profit -232.87 39.64 -110.21 23.39 13.65
EPS -229.05 73.63 -103.95 25.42 14.69
Book Value -- -- -71.75 -- -7.13
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-23Dec-22Dec-21
EBIT-Margin info -1,672.38-1,617.29---2,068.49-1,276.26
Net Margin info ---676.48------
Return on equity info -219.69-57.89-57.28-678.3976.60
Return on Capital info 247.28-277.67-44.40638.22148.03
Return on Assets info -0.94-20.86-30.3176.18-48.69
Debt to Equity (x) info ------0.48-0.52

Profitability

View Detailed Peer Comparison

ROCE

-44.40

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-44.40
638.22
148.03
193.15
-2,323.37
Peer Median
--
--
--
--
--
ROE

-57.28

--

Profit after tax / Average Net worth * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-57.28
-678.39
76.60
83.11
286.51
Peer Median
--
--
--
--
--
ROA

-30.31

--

Profit after tax / Average Total assets * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-30.31
76.18
-48.69
-51.23
-50.25
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
-2,068.49
-1,276.26
-756.33
-2,368.06
Peer Median
--
--
--
--
--
Net Margin

-1,580.18

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-1,580.18
2,696.50
-1,245.53
-433.76
-919.20
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.63

--

Year on year growth in net sales

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-0.63
-0.37
-0.48
1.37
0.06
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
-1.86
12.20
24.43
-54.15
Peer Median
--
--
--
--
--
Net Profit Growth

-121.54

--

Year on year growth in profit after tax

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-121.54
236.06
13.08
24.16
-12.92
Peer Median
--
--
--
--
--
EPS Growth

-1.09

--

Year on year growth in earnings per share

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-1.09
2.17
0.37
0.35
0.00
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
0.48
-0.52
-0.46
-0.72
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
0.34
-0.27
-0.18
-0.14
Peer Median
--
--
--
--
--
Current Ratio

2.56

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
2.56
1.78
3.00
2.66
5.27
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
1.70
2.94
2.56
5.02
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
-31.77
-15.70
-12.39
-45.25
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
17.45
5.68
11.72
22.72
Peer Median
--
--
--
--
--
Asset Turnover

0.02

--

Sales / Average Total Assets

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
0.02
0.03
0.04
0.07
0.02
Peer Median
--
--
--
--
--
Receivable days

173.37

--

Average Debtors / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
173.37
48.36
51.52
38.95
73.48
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
161.34
133.19
148.99
111.33
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
293.29
236.40
134.94
101.70
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
--
-83.58
-51.69
52.99
83.11
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-1.22

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-1.22
0.35
-0.10
-0.14
-0.16
Peer Median
--
--
--
--
--
Price / Book Value

0.89

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
0.89
0.77
-0.10
-0.10
-0.20
Peer Median
--
--
--
--
--
EV/EBITDA

-0.19

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
AcelRx Pharmaceuticals (ACRX)
-0.19
-0.38
0.95
0.31
0.54
Peer Median
--
--
--
--
--
loading...
loading...